PRESS RELEASE published on 07/25/2025 at 08:45, 7 months 23 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 11 months 13 days ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
BRIEF published on 02/28/2025 at 19:33, 1 year ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
BRIEF published on 02/26/2025 at 08:47, 1 year ago ADOCIA strengthens its cash flow with a private placement of 9.7 million euros Private Placement Capital Increase Biopharmaceutical Third Party Capital Financial Tonnage
PRESS RELEASE published on 02/26/2025 at 08:42, 1 year ago Inside Information / Operations of the issuer (acquisitions, sales...) Adocia successfully completes €9.7 million private placement, extending cash runway to Q2 2026. New shares issued with warrants attached. Notable investors include Gerard Soula and Armistice Capital Private Placement Investors New Shares Cash Runway ADOCIA
BRIEF published on 02/25/2025 at 19:08, 1 year ago Adocia: Financial report for the fourth quarter of 2024 Diabetes Treasury Partnership ADOCIA BioChaperone®
PRESS RELEASE published on 02/25/2025 at 19:03, 1 year ago Inside Information / News release on accounts, results Adocia reports Q4 2024 financial results, €7.5M cash position, partnership updates with Sanofi, and business priorities. Strong revenue growth detailed in press release Financial Results Revenue Growth ADOCIA Partnership Updates Business Priorities
BRIEF published on 02/11/2025 at 14:03, 1 year 1 month ago Threshold crossing at ADOCIA by the CDC Actions Threshold Crossing Bpifrance ADOCIA Deposit Fund
BRIEF published on 12/23/2024 at 18:40, 1 year 2 months ago Adocia announces its participation in key conferences in 2025 Investors Biopharmaceutical ADOCIA Conférences 2025 Diabetes And Obesity
Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 5 hours 17 minutes ago Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 5 hours 47 minutes ago High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 6 hours 17 minutes ago Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho
Published on 03/17/2026 at 17:58, 49 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 15:30, 3 hours 17 minutes ago Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy
Published on 03/17/2026 at 15:19, 3 hours 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 03/17/2026 at 07:00, 11 hours 47 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:56, 1 day ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
